Nephros, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on May 2, 2008, covering events occurring on April 28, 2008. The filing addresses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
Material Changes
- Executive Departure: Mark W. Lerner resigned as Chief Financial Officer effective April 28, 2008.
- Executive Appointment: Gerald J. Kochanski was appointed as the new Chief Financial Officer effective April 28, 2008.
- Compensation Structure: Mr. Kochanski's employment agreement includes an annual base salary of $185,000, a $10,000 commuting allowance for the first year, and up to $10,000 in moving cost reimbursement.
- Equity Grant: Mr. Kochanski received an option to purchase 250,000 shares of common stock, vesting in four equal annual installments starting March 31, 2009, with full acceleration upon a Change in Control.
Outlook, Risks, and Management Commentary
Management indicated that discussions are ongoing with Mr. Lerner regarding his potential role in assisting with the transition. The employment agreement outlines specific severance provisions, including salary continuation for three to six months in the event of termination without cause, contingent upon the execution of a release. The agreement also defines termination rights and compensation in the event of a Change in Control.
Key Facts for Investor Verification
- Confirm the effective date of Mr. Lerner's resignation and Mr. Kochanski's appointment (April 28, 2008).
- Verify the vesting schedule for the 250,000 stock options granted to Mr. Kochanski.
- Review the specific definitions of "Cause," "Disability," and "Change in Control" within the employment agreement to understand severance triggers.
- Note that this filing contains no financial results; investors should refer to the most recent 10-Q or 10-K for financial metrics.